TG Therapeutics | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
AbbVie USD 18M 0 2024-12
Alaunos Therapeutics USD 2K 0 2024-09
Amgen USD 33.53B 140M 2024-12
Ardelyx USD 24K 0 2024-12
Arrowhead Research USD 218K 1000 2024-12
Bayer EUR 2.52B 0 2024-12
Biogen USD 100K 0 2024-12
Corcept Therapeutics USD 136K 1000 2024-12
Dynavax Technologies USD 125K 6K 2024-12
Gilead Sciences USD 1000K 0 2024-12
J&J USD 3.12B 0 2024-12
Novartis USD 793M 0 2024-12
PTC Therapeutics USD 77K 1000 2024-12
Regeneron Pharmaceuticals USD 100K 2K 2024-09
Roche Holding CHF 107M 0 2024-06
TG Therapeutics USD 156K 0 2024-12
Vertex Pharmaceuticals USD 2.6M 0 2024-12



TG Therapeutics Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.